New Findings Raise Concerns on Abortion Pill Safety

This chapter examines new findings regarding the FDA's regulation of mifepristone, highlighting safety concerns raised by a recent study involving over 865,000 abortions. The speaker calls for a reconsideration of existing guidelines and shares strong opposition to the drug's continued availability due to ethical implications.